[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369857-105":59,"doc-detail-369857-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","cdc6-as-a-pan-cancer-immunological-and-prognostic-biomarker-and-its-role-in-suppressing-melanoma-malignancy","CDC6 as a pan-cancer immunological and prognostic biomarker and its role in suppressing melanoma malignancy","","Cell division cycle 6 (CDC6) functions as a licensing factor for DNA replication and supports the S-M checkpoint, promoting genomic stability. Dysregulation of CDC6 has been reported across multiple cancers, yet a unified pan-cancer evaluation of its diagnostic, prognostic, and immunomodulatory value remained insufficient. This study integrates multi-omics resources to characterize CDC6 across cancers, assesses immune microenvironment relationships and DNA methylation links, and experimentally validates CDC6-driven proliferation, invasion, and migration in melanoma.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cdc6-as-a-pan-cancer-immunological-and-prognostic-biomarker-and-its-role-in-suppressing-melanoma-malignancy/369857/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cdc6-as-a-pan-cancer-immunological-and-prognostic-biomarker-and-its-role-in-suppressing-melanoma-malignancy/369857.png","ImageObject",300,407,{"name":92,"@type":93},"Kurz","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is CDC6 and why is it relevant to cancer?","Question",{"text":112,"@type":113},"CDC6 is a DNA replication licensing factor and supports the S-M checkpoint for genomic stability. Its dysregulation is linked to tumor progression and therapy resistance across cancers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was CDC6 investigated in this study?",{"text":117,"@type":113},"Multi-omics datasets from TCGA, GTEx, cBioPortal, HPA, UALCAN, and SangerBox were integrated using systematic bioinformatics. Prognostic associations, mutation patterns, tumor immune microenvironment infiltration, and DNA methylation regulation were analyzed.",{"name":119,"@type":110,"acceptedAnswer":120},"What key findings connect CDC6 to cancer prognosis and immunity?",{"text":121,"@type":113},"CDC6 was consistently upregulated across multiple malignancies and correlated with prognosis. Its expression also showed robust associations with immune cell infiltration patterns and DNA methylation alterations in multiple cancer types.",{"name":123,"@type":110,"acceptedAnswer":124},"How did the study validate CDC6’s role in melanoma?",{"text":125,"@type":113},"Functional experiments assessed melanoma cell proliferation, invasion, and migration. CDC6 overexpression significantly promoted these oncogenic behaviors in melanoma.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},369857,1790580662,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},2336478945635,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Mo etal. BMC Cancer (2025) 25:1426 BMC Cancer  \n[https://doi.org/10.1186/s12885-025-14782-w](https://doi.org/10.1186/s12885-025-14782-w)  \nRESEARCH Open Access  \nCDC6 as a pan-cancer immunological and prognostic biomarker and its role in suppressing melanoma malignancy  \nLijun Mo 1*†, Min Jia 1†, Qian Wu 1, Qingqing Xu 1, Zhida Mai 1, Bo Fu 1, Zhengqiang He 1, Mingchang Huang 1, Yinyuan Lan 1, Qiaozhen Xu 1, Zhenmou Xie 1, Xiaoni He2 andYaohua Xue 1*  \nAbstract  \nBackground Cell division cycle 6 (CDC6) is a key licensing factor for DNA replication in the G1 and S phases.  \nBesides initiating replication, CDC6 also helps establish and maintain the S-M checkpoint, ensuring genomic stability. Emerging evidence highlights its dysregulation in various cancers, implicating CDC6 in tumor progression and therapy resistance. However, a comprehensive pan-cancer analysis evaluating its diagnostic, prognostic and immunomodulatory potential remains lacking, underscoring the need for further investigation.  \nMethods By integrating multi-omics datasets from The Cancer Genome Atlas (TCGA), Genotype-Tissue  \nExpression Project (GTEx), cBioPortal, Human Protein Atlas (HPA), UALCAN and SangerBox, we employed systematic bioinformatics approaches to investigate the oncogenic role of CDC6 across multiple cancer types. Our analysis encompassed prognostic associations, mutational landscapes, tumor immune microenvironment (TIME) infiltration patterns and epigenetic regulation via DNA methylation, providing a pan-cancer perspective on CDC6’s potential role in tumorigenesis. In addition, CDC6’s role in melanoma cell proliferation, invasion and migration was experimentally assessed.  \nResults Pan-cancer analysis demonstrated CDC6 as a consistently upregulated oncogene across multiple malignancies, exhibiting significantly elevated expression compared to normal tissues. Notably, CDC6 is closely associated with prognosis across various cancer types. Our investigation further revealed robust correlations between CDC6 expression and immune cell infiltration patterns. Epigenetic profiling identified significant associations between CDC6 expression and DNA methylation alterations in nine cancer types. Functional studies validated CDC6’soncogenic role, where its overexpression significantly promoted cellular proliferation, migration and invasion in melanoma.  \nConclusions Our study demonstrates that CDC6 serves as a crucial oncogenic driver across diverse tumor types, establishing its dual utility as a diagnostic biomarker and independent prognostic indicator. Importantly, we identified  \n†Lijun Mo and Min Jia contributed equally to this work.  \n*Correspondence:  \nLijun Mo [molijun@smu.edu.cn](molijun@smu.edu.cn)[ ](molijun@smu.edu.cn)Yaohua Xue [xueyaohua@smu.edu.cn](xueyaohua@smu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nMo et al. BMC Cancer (2025) 25:1426 ","cbCaigg1ewHzHATb","https://ap.wps.com/l/cbCaigg1ewHzHATb","pdf",4206684,17,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Background","[{\"question\":\"What is CDC6 and why is it relevant to cancer?\",\"answer\":\"CDC6 is a DNA replication licensing factor and supports the S-M checkpoint for genomic stability. Its dysregulation is linked to tumor progression and therapy resistance across cancers.\"},{\"question\":\"How was CDC6 investigated in this study?\",\"answer\":\"Multi-omics datasets from TCGA, GTEx, cBioPortal, HPA, UALCAN, and SangerBox were integrated using systematic bioinformatics. Prognostic associations, mutation patterns, tumor immune microenvironment infiltration, and DNA methylation regulation were analyzed.\"},{\"question\":\"What key findings connect CDC6 to cancer prognosis and immunity?\",\"answer\":\"CDC6 was consistently upregulated across multiple malignancies and correlated with prognosis. Its expression also showed robust associations with immune cell infiltration patterns and DNA methylation alterations in multiple cancer types.\"},{\"question\":\"How did the study validate CDC6’s role in melanoma?\",\"answer\":\"Functional experiments assessed melanoma cell proliferation, invasion, and migration. CDC6 overexpression significantly promoted these oncogenic behaviors in melanoma.\"}]","CDC6 as a pan-cancer immunological and prognostic biomarker and its role in suppressing melanoma malignancy | PDF",1790184915,43,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/598c51ba41e57fec4db016f5c5fb20ec.webp",983,1310,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6480e214a1865946ca307247a2dfac08.webp",982,1309,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0fc7e7b7e07947493a524f4854cc5ecc.webp",981,1308,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/85a64304fed13f2860c00d2369527c63.webp",980,1306]